Oxybutynin Chloride Extended Release Tablets Usp 10mg 100 Ct Label
Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 64980-211
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 64980-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Oxybutynin Chloride Extended Release Tablets Usp 15mg 100 Ct Label
Oxybutynin Chloride Extended Release Tablets Usp 5mg 100 Ct Label
A useful description cannot be generated from the provided text. It appears to be a mix of different characters and does not form coherent sentences or words. It is possible that the text was not recognized by correctly.*
Figure 1 (Fig 1)
The text provides a graph titled "Mean Plasma R-Oxybutynin Concentration (ng/mL)" comparing the concentrations of oxybutynin chloride extended-release tablets at 10 mg once daily versus oxybutynin at 5 mg three times daily over a period of 16 hours. Therefore, the text describes the pharmacokinetics of two different dosing regimens of oxybutynin.*
Figure 2 (Fig 2)
Figure 3
Figure 4
Oxybutynin is a medication that is available in extended-release tablets. Unfortunately, no additional information is available from the provided text.*
Figure 5
This text appears to be a list of components of a medication. Specifically, it includes the name of the medication "Oxybutynin chloride" and the presentation of the tablets "extended-release".*
Rising Logo
Structure (Structural Formula)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
